Medicare Enrolled

Dr. Adriana Gonzalez, MD

Endocrinology · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1701 SUNSET BLVD, Houston, TX 77005
7135265511
In practice since 2013 (12 years)
NPI: 1003250796 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gonzalez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gonzalez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gonzalez

Dr. Adriana Gonzalez is an endocrinology in Houston, TX, with 12 years in practice. Based on federal Medicare data, Dr. Gonzalez performed 3,061 Medicare services across 719 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gonzalez received a total of $14,209 from 52 pharmaceutical and/or device companies across 626 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gonzalez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice▲ Top 13% volume in TX$ $14,209 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,061
Medicare services
Top 13% in TX for endocrinology
719
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~255 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)2,280$19$47
Office visit, established patient (30-39 min)348$96$342
New patient office visit (45-59 min)103$119$418
Office visit, established patient (20-29 min)96$64$269
Drug injection, under skin or into muscle71$12$63
New patient office visit, complex (60-74 min)30$163$403
Office visit, established patient, complex (40-54 min)28$142$267
Blood glucose (sugar) test performed by hand-held instrument26$3$21
Telephone medical discussion with physician, 21-30 minutes20$94$542
Bone density scan (DEXA)17$39$39
Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk14$33$42
Hemoglobin A1c test (diabetes monitoring)14$10$74
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report14$28$45
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,209
Total received (2018-2024)
Avg $2,030/year across 7 years
Top 27% in TX for endocrinology
52
Companies
626
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,476 (87.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,733 (12.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,599
2023
$523
2022
$274
2021
$296
2020
$6,231
2019
$3,493
2018
$793

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic MiniMed, Inc.
$1,842
IBSA Pharma Inc.
$1,795
Novo Nordisk Inc
$1,314
Amgen Inc.
$1,054
SANOFI-AVENTIS U.S. LLC
$811
Abbott Laboratories
$705
Dexcom, Inc.
$574
AstraZeneca Pharmaceuticals LP
$467
Corcept Therapeutics
$448
Insulet Corporation
$445
Radius Health, Inc.
$383
Boehringer Ingelheim Pharmaceuticals, Inc.
$357
Lilly USA, LLC
$312
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$232
Horizon Therapeutics plc
$216
Mannkind Corporation
$215
Shire North American Group Inc
$203
Amneal Pharmaceuticals LLC
$200
Antares Pharma, Inc.
$194
Novartis Pharmaceuticals Corporation
$176
Companion Medical, Inc.
$158
Nevro Corp.
$154
Merck Sharp & Dohme Corporation
$148
Senseonics, Incorporated
$147
Endo Pharmaceuticals Inc.
$127
Medtronic, Inc.
$126
AbbVie Inc.
$121
Janssen Pharmaceuticals, Inc
$118
Amarin Pharma Inc.
$106
Esperion Therapeutics, Inc.
$102
Zealand Pharma US, Inc.
$100
AbbVie, Inc.
$100
PFIZER INC.
$94
Kowa Pharmaceuticals America, Inc.
$70
Bayer Healthcare Pharmaceuticals Inc.
$66
MannKind Corporation
$61
Tandem Diabetes Care, Inc.
$58
BETA BIONICS, INC.
$53
Astellas Pharma US Inc
$48
CeQur Corporation
$43
Xeris Pharmaceuticals, Inc.
$42
Currax Pharmaceuticals LLC
$39
Valeritas, Inc.
$37
VIVUS, Inc.
$32
Allergan, Inc.
$18
Kyowa Kirin, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$15
GlaxoSmithKline, LLC.
$15
Gemini Laboratories, LLC
$14
Optinose US, Inc.
$14
RECORDATI_RARE_DISEASES_INC.
$13
Boston Scientific Corporation
$13
Top 3 companies account for 34.8% of total payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Androgel · BAQSIMI · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G7 GSS (161) · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · HUMULIN U · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LITHOVUE · LYRICA · Livalo · MINIMED 780G · MOUNJARO · Minimed 670G System · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · Prolia · QSYMIA · QUVIVIQ · RAYOS · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SOTAGLIFLOZIN · SYNTHROID · Saxenda · Senza · Synthroid · TEPEZZA · TESTOPEL · TOUJEO · TZIELD · Tirosint · Tymlos · UNITHROID · V-GO · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xhance · ZEGALOGUE · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $464 per 100 Medicare services performed
Looking for a endocrinology in Houston?
Compare endocrinologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
149
Per 100K population
3.1
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
1.6 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gonzalez is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gonzalez experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Gonzalez performed 2,280 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gonzalez receive payments from pharmaceutical companies?
Yes. Dr. Gonzalez received a total of $14,209 from 52 companies across 626 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gonzalez's costs compare to other endocrinologys in Houston?
Dr. Gonzalez's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gonzalez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →